The studies of signaling mechanisms involved in the disruption of the cytoskeleton homeostasis were performed in a model of quinolinic acid (QUIN) neurotoxicity in vitro. This investigation focused on the phosphorylation level of intermediate filament (IF) subunits of astrocytes (glial fibrillary acidic protein -GFAP) and neurons (low, medium and high molecular weight neurofilament subunits -NFL, NFM and NFH, respectively). The activity of the phosphorylating system associated with the IFs was investigated in striatal slices of rat exposed to QUIN or treated simultaneously with QUIN plus glutamate receptor antagonists, calcium channel blockers or kinase inhibitors. Results showed that in astrocytes, the action of 100 μM QUIN was mainly due to increased Ca 2 + influx through NMDA and L-type voltage-dependent Ca 2 + channels (L-VDCC). In neuronal cells QUIN acted through metabotropic glutamate receptor (mGluR) activation and influx of Ca 2 + through NMDA receptors and L-VDCC, as well as Ca 2 + release from intracellular stores. These mechanisms then set off a cascade of events including activation of PKA, PKCaMII and PKC, which phosphorylate head domain sites on GFAP and NFL. Also, Cdk5 was activated downstream of mGluR5, phosphorylating the KSP repeats on NFM and NFH. mGluR1 was upstream of phospholipase C (PLC) which, in turn, produced diacylglycerol (DAG) and inositol 3,4,5 triphosphate (IP3). DAG is important to activate PKC and phosphorylate NFL, while IP 3 contributed to Ca 2 + release from internal stores promoting hyperphosphorylation of KSP repeats on the tail domain of NFM and NFH. The present study supports the concept of glutamate and Ca 2 + contribution in excitotoxic neuronal damage provoked by QUIN associated to dysfunction of the cytoskeleton homeostasis and highlights the differential signaling mechanisms elicited in striatal astrocytes and neurons.
Introduction
Quinolinic acid (QUIN) is an intermediate of the kynurenine pathway, a central route in tryptophan (TRP) metabolism in most mammalian tissues. The kynurenine pathway has been demonstrated to be involved in many diseases and disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, AIDS dementia complex, malaria, cancer, depression and schizophrenia (Chen and Guillemin, 2009) .
QUIN is a co-agonist of the NMDA receptor subgroup containing the NR2A and NR2B subunits (de Carvalho et al., 1996) , with low receptor affinity. It is known that QA can cause excitotoxicity through a direct activation of NMDA receptors (Stone and Perkins, 1981) due to inhibition of release and uptake of endogenous glutamate (Connick and Stone, 1988; Tavares et al., 2002) . In this context, it is generally accepted that excitotoxic cell death elicited by QUIN involves bioenergetic failure resulting from Ca 2+ overload and the generation of reactive oxygen species (ROS) by mitochondria (Behan et al., 1999; Rios and Santamaria, 1991) . QUIN at high concentrations is an excitotoxin that produces a pattern of cell death that mimics the selective neuronal vulnerability seen in Huntington's disease patients with loss of striatal neurons (Beal et al., 1986; Estrada Sanchez et al., 2008) . Intrastriatal QUIN injection has been used as a model of neurotoxicity loading striatal degeneration, behavioral, biochemical and cellular alterations (Kalonia et al., 2011a) and oxidative damage (Kalonia et al., 2011b) .
The neuronal cytoskeleton comprises a protein network formed mainly by microtubules (MT) and neurofilaments (NF), the IFs of neurons. NF, known as type IV IF, are composed of three different polypeptides whose approximate molecular weights are 200, 160, and 68 kDa, and are commonly referred to as heavy (NFH), medium (NFM), and light (NFL) NF subunits (Ackerley et al., 2003) . Type III IF proteins includes vimentin, desmin, glial fibrillary acidic protein (GFAP) and peripherin. GFAP is the IF of mature astrocytes (Eng et al., 2000) , peripherin is found in neural cells of the peripheral nervous system, and vimentin is the IF of cells of mesenchymal origin (Albert et al., 2008) . Otherwise, desmin constitutes the IF of muscle cells (Albert et al., 2008) . IFs play an important structural or tension-bearing role in the cell. Evidence is now emerging that IFs also act as an important framework for the modulation and control of essential cell processes, in particular, signal transduction events (Kim and Coulombe, 2007; Paramio and Jorcano, 2002) .
Protein phosphorylation is the most widespread type of posttranslational modification used in signal transduction (Ubersax and Ferrell, 2007) affecting basic cellular processes, including regulation of the structural organization of the cytoskeleton (Fuchs and Weber, 1994; Sihag et al., 2007) . Accordingly, phosphorylation of types III and IV (NF triplet proteins and α-internexin) IFs is known to regulate their organization and function (Sihag et al., 2007) . IF proteins are known to be phosphorylated on their head and tail domains. Type III filaments are phosphorylated on head domain sites by second messengerdependent protein kinases and it is described that phosphorylation plays a major role in regulating the assembly/disassembly of these filaments (Sihag et al., 2007) . Similarly, the three subunits of NFs are highly phosphorylated (Shea and Chan, 2008) . The major sites of phosphorylation of NFL and NFM subunits were identified as Ser-55, which is phosphorylated by protein kinase A (PKA), Ser-57 phosphorylated by Ca 2 + / calmodulin-dependent protein kinase II (PKCaMII), Ser-51 for protein kinase C (PKC) (Gill et al., 1990; Heins et al., 1993) , and Ser-23 for PKA and protein kinase C (PKC), respectively (Daile et al., 1975; Kemp et al., 1975) . Nonetheless, PKCaMII is able to phosphorylate head domain sites on NFL subunit in vitro (Songyang et al., 1994) . On the other hand, most of the phosphorylation sites on NFM and NFH are located on multiple lysine-serine-proline (KSP) repeat motifs abundant in the carboxyl-terminal tail domain of these NF subunits (Geisler et al., 1987; Lee et al., 1988; Xu et al., 1992) . It is now evident that proline-directed kinases, such as cyclin-dependent kinase 5 (Cdk5) and mitogen-dependent protein kinase (MAPK) are the main kinases that phosphorylate Ser residues on the KSP repeats Sun et al., 1996; Veeranna et al., 1998) . The C-terminal regions of NFH and NFM protrude laterally from the filament backbone when phosphorylated (Sihag et al., 2007) and a considerable body of evidence, supports the notion that phosphorylation of C-terminal side arms, in particular those of NFH, regulates NF axonal transport (Shea and Chan, 2008) . This is in concern with the evidence that carboxylterminal phosphorylation of NFH progressively restricts association of NFs with the anterograde motor kinesin, providing one mechanism by which the NF axonal transport is slowed (Yabe et al., 2000) . In fact, perykarial accumulations/aggregations of aberrantly phosphorylated NFs are a pathological feature of several human neurodegenerative diseases, such as Alzheimer's disease, motor neuron diseases and Parkinson's disease (Grant and Pant, 2000; Lariviere and Julien, 2004; Nixon, 1993; Nixon and Sihag, 1991; Sasaki et al., 2006) .
In this context, we have recently described that acute intrastriatal administration of QUIN targets the phosphorylating system associated with the cytoskeleton of neural striatal cells, causing IF hyperphosphorylation 30 min after injection (Pierozan et al., 2010) . These findings suggested the participation of QUIN-elicited transduction pathways targeting the cytoskeleton. Therefore, misregulation of the phosphorylating system associated with IF proteins could represent an early step in the pathophysiological cascade of deleterious events exerted by QUIN in rat striatum. However, the cell signaling cascades in QUINinduced IF hyperphosphorylation are incompletely understood. To extend the scope of our previous findings, the purpose of the present study was to elucidate the signaling mechanisms provoking hyperphosphorylation of IF proteins focusing in the differential pathways attaining neuronal and glial cells in striatal slices exposed to QUIN.
Materials and methods

Radiochemical and compounds
[ 32 P]Na 2 HPO 4 was purchased from Comissão Nacional de Energia Nuclear (CNEN), São Paulo, Brazil. Quinolinic acid, 1,2-bis (2-aminophenoxy) ethane-N-N-N′-N′-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM), D-2-amino-5-phosphonopentanoic acid (DP-AP5), ethylene glycol tetraacetic acid (EGTA), verapamil hydrochloride, dantrolene, phaclophen, bicuculine, staurosporine, benzamidine, leupeptin, antipain, pepstatin, chymostatin, acrylamide, bisacrilamide, SP600125, and roscovitine were obtained from Sigma (St. Louis, MO, USA). KN-93, PD98056 and H89 were obtained from Calbiochem (La Jolla CA, USA). Anti-pNFL(Ser55), anti-pNFL(Ser57) and p38 inhibitor were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX), (S)-α-methyl-4-carboxyphenylglycine (MCPG), 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) and (S)-4-carboxy-3-hydroxyphenylglycine (4C3HPG) were obtained from Tocris Bioscience (Ellisville, Missouri, USA). Pictrotoxin was obtained from TCI America (Portland, OR, USA). The antibody NFH (anti-KSP repeats) was from Chemicon (Temecula, CA, USA). The chemiluminescence ECL kit peroxidase and the conjugated anti-rabbit IgG were obtained from Amersham (Oakville, Ontario, Canada). All other chemicals were of analytical grade.
Animals
Thirty-day-old Wistar rats obtained from Central Animal House of the Departament of Biochemistry Federal University of Rio Grande do Sul, Porto Alegre, Brazil, were used in the experiments. The animals were maintained on a 12:12 h light/dark cycle in an air-conditioned constant temperature (22°C ± 1°C) colony room, with food and water at libitum. The experimental protocol followed the "Principles of Laboratory Animal Care" (NHI publication 85-23, revised 1985) and was approved by the Ethics Committee for Animal Research of the Federal University of Rio Grande do Sul.
Preincubation
Rats were sacrificed by decapitation, the striatum was dissected onto Petri dishes placed on ice and cut into 400 μm thick slices with a McIlwain chopper. Tissue slices were initially preincubated at 30°C for 10 min in a Krebs-Hepes medium containing 124 mM NaCl, 4 mM KCl, 1.2 mM,MgSO 4 , 25 mM Na-Hepes (pH 7.4), 12 mM glucose, 1 mM CaCl 2 , and the following protease inhibitors: 1 mM benzamidine, 0.1 μM leupeptin, 0.7 μM antipain, 0.7 μM pepstatin and 0.7 μM chymostatin in the presence or absence of 100 mM DL-AP5, 50 μM BAPTA-AM, 1 mM EGTA, 30 μM verapamil, 50 μM dantrolene, 10 μM KN93, 1 μM staurosporine, 30 μM PD98059 and 10 μM U73122 (Loureiro et al., 2008) , 50 μM CNQX, 100 μM MCPG (Loureiro et al., 2005) , 10 μM H89 (Cortes et al., 2010) , 30 μM SP600125 (Katayama et al., 2009) , 10 μM p38 MAPK inhibitor VIII (Rigon et al., 2008) , 10 μM roscovitine (Tomizawa et al., 2002) , 20 μM bicuculine and 100 μM picrotoxin (Adermark et al., 2010) , 10 μM phaclofen (Seto et al., 2002) , 30 μM MPEP hydrochloride (Domenici et al., 2004) and 30 μM (S)-4-carboxy-3-hydroxyphenylglycine (Orlando et al., 2001) , when indicated.
Incubation
After preincubation, the medium was changed by 100 ml of the basic medium with or without 100 μM QUIN and/or the inhibitors cited above, and incubation was carried out for 20 min at 30°C. After this, 100 μCi of [ 32 P]-orthophosphate was added to the incubation medium and the labeling reaction was allowed to proceed for 30 min at 30°C. Reaction was stopped with 1 ml of cold stop buffer (150 mM NaF, 5 mM, EDTA, 5 mM EGTA, 50 mM Tris-HCl, pH 6.5, and the protease inhibitors described above). Slices were then washed twice with stop buffer to remove excess radioactivity.
Preparation of the high salt-triton-insoluble cytoskeletal fraction from tissue slices After treatment, preparations of IF-enriched cytoskeletal fractions were obtained from striatum of rats as previously described by us (Funchal et al., 2003) . Briefly, after the labeling reaction, slices were homogenized in 400 ml of ice-cold high salt buffer containing 5 mM KH 2 PO 4 , (pH 7.1), 600 mM KCl, 10 mM MgCl 2 , 2 mM EGTA, 1 mM EDTA, 1% Triton X-100 and the protease inhibitors described above. The homogenate was centrifuged at 15,800 ×g for 10 min at 4°C, in an Eppendorf centrifuge, the supernatant discarded and the pellet homogenized with the same volume of the high salt medium. The resuspended homogenate was centrifuged as described and the supernatant was discarded. The Triton-insoluble IF-enriched pellet, containing NF subunits and GFAP, was dissolved in 1% SDS.
Total tissue homogenate
Tissue slices from striatum were homogenized in 100 ml of a lysis solution containing 2 mM EDTA, 50 mM Tris-HCl, pH 6.8, 4% (v\v) SDS. For electrophoresis analysis, samples were dissolved in 25% (v\v) of solution containing 40% glycerol, 5% mercaptoethanol, 50 mM TrisHCl, pH 6.8 and boiled for 3 min.
Cell integrity
Measurement of cell integrity was determined by lactate dehydrogenase (LDH) activity using a colorimetric commercial kit (from Doles, Brazil), (Whitaker and McKay, 1969) . Total LDH activity was determined after adding a final concentration of 10% Triton X-100 and disrupting the slices by homogenization with a Tissue Tearor (Biospec). Results were expressed as percentage relative to 100% LDH activity.
Cell viability
Mitochondrial dehydrogenase activity to reduce MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was used to determine cell survival (Liu et al., 1997) . The tetrazolium ring of MTT is cleaved by various dehydrogenase enzymes in active mitochondria and then precipitated as a blue formazan product. Striatal slices were incubated with MTT (0.5 mg/mL) in KRB buffer, pH 7.4 (122 mM Na-gluconate, 5 mM K-gluconate, 2 mM HEPES, 25 mM NaHCO 3 , 1 mM MgSO 4 , 1.2 mM NaH 2 PO 4 , 0.9 mM Ca-gluconate, 1 mM L-glutamine, 5 mM glucose; KRB buffer) for 20 min at 37°C. The medium was then aspirated, the precipitated formazan was solubilized with dimethyl sulfoxide, and viable cells were quantified spectrophotometrically at a wavelength of 550 nm.
Polyacrylamide gel electrophoresis (SDS-PAGE)
The cytoskeletal fraction and total tissue homogenate were prepared as described above. For electrophoresis analysis, samples were dissolved 25% (v/v) in a solution containing 40% glycerol, 5% mercaptoethanol, 50 mM Tris-HCl, pH 6.8 and boiled for 3 min. Samples containing equal protein content (50 μg) were loaded onto 7% or 10% polyacrylamide gels and analyzed by SDS-PAGE according to the discontinuous system of Laemmli (Laemmli, 1970) . In the in vitro 32 P incorporation experiments, the gels containing the IF-enriched cytoskeletal fraction were exposed to X-ray films (T-mat G/RA) at −70°C with intensifying screens and finally the autoradiograph was obtained. Cytoskeletal proteins were quantified by scanning the films with a Hewlett-Packard Scanjet 6100C scanner and determining optical densities with an Optiquant version 02.00 software (Packard Instrument Company). Optical density values were obtained for the band corresponding to each protein. Protein loading was controlled by Comassie blue R staining or actin immunoblotting. All bands being measured were within the linear range of the film.
Western blot analysis
Cytoskeletal fractions (50 μg) were analyzed by SDS-PAGE and transferred to nitrocellulose membranes (Trans-blot SD semi-dry transfer cell, BioRad) for 1 h at 15 V in transfer buffer: 48 mM Trizma, 39 mM glycine, 20% methanol and 0.25% SDS. The nitrocellulose membranes were washed for 10 min in Tris buffered saline (TBS; 0.5 M NaCl, 20 mM Trizma and pH 7.5), followed by 2 h incubation in blocking solution (TBS plus 5% defatted dried milk). After incubation, the blots were washed twice for 5 min with TBS plus 0.05% Tween-20 (T-TBS), and then incubated overnight at 4°C in blocking solution containing the following monoclonal antibodies: anti-p-NFL(Ser55) diluted 1:800, antip-NFL(Ser57) diluted 1:800, anti-NFH/NFM KSP repeats diluted 1:100 and anti-β-actin diluted 1:1000. The blot was then washed twice for 5 min with T-TBS and incubated for 2 h in TBS containing peroxidase conjugated rabbit anti-mouse IgG or anti-rabbit IgG diluted 1:2000. In addition, we used the following negative controls: antibody negative control (lacking the sample containing the antigen of interest) and sample negative control (lacking the first antibody). These controls (not shown) stated the specificity and sensibility of the antibodies. The blot was washed twice again for 5 min with T-TBS and twice for 5 min with TBS. The blot was then developed using a chemiluminescence ECL kit and quantified as described above.
Protein determination
The protein concentration was determined by the method of Lowry (Lowry et al., 1951) using serum bovine albumin as the standard.
Statistical analysis
Data were analyzed statistically by one-way analysis of variance (ANOVA) followed by the Tukey-Kramer post hoc comparison when the F-test was significant. A p b 0.05 was considered significant. All analyses were performed using the SPSS software program on an IBM-PC compatible computer.
Results
We initially evaluated the cell integrity of mitochondrial damage in our experimental model, measuring LDH extracellular activity and MTT which indicates overall mitochondrial dehydrogenase activity, respectively. Our results showed that the in vitro treatment with 100 μM QUIN preserved cell integrity and viability in striatal slices of 30 dayold rats (results not shown). Thereafter, we studied the effect of QUIN on the phosphorylation of IF-enriched cytoskeletal fraction of striatal slices. Results showed that after 50 min exposition to 100 μM QUIN the phosphorylation level of NF subunits (NFL, NFM and NFH) and GFAP was increased (Fig. 1) , suggesting that the cytoskeleton of both neurons and astrocytes of striatal slices is an important in vitro target of QUIN at a concentration described to be neurotoxic (Perez-De La Cruz et al., 2010) .
Action of QUIN on the second messenger-dependent and -independent kinases targeting the IF proteins in astrocytes and neurons of striatal slices
Since it is described that the second messenger-dependent protein kinases are able to phosphorylate sites at GFAP and NFL head domains (Hisanaga et al., 1990; Sihag and Nixon, 1989; Sihag et al., 2007) , we focused on the role of PKA, PKCaMII and PKC mediating the action of QUIN on the phosphorylation level of these IF subunits. Results showed that H89 (PKA inhibitor) and KN93 (PKCaMII inhibitor) prevented hyperphosphorylation of GFAP and NFL without affecting the QUIN-induced NFM and NFH hyperphosphorylation. Conversely, staurosporine, a specific PKC inhibitor, was ineffective in preventing GFAP hyperphosphorylation and only partially prevented this effect on NFL ( Fig. 2A) .
In order to identify the kinases targeting the phosphorylating sites on NFM and NFH subunits, we used specific MAP kinases and Cdk5 inhibitors. Results showed that PD98059, a MAPKK (MEK) inhibitor and p38 MAPK inhibitor VIII were not able to prevent the QUIN-induced NFM and NFH hyperphosphorylation, while SP600125, a JNK inhibitor P-orthophosphate. The cytoskeletal fraction was extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP was measured as described in Materials and methods. Data are reported as mean± S.D. of 18 animals in each group and expressed as percent of controls. Statistically significant differences from controls, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: ***p b 0.001compared with control and ###pb 0.001 compared with QUIN group. B) Coomassie blue stained molecular weight standards and representative stained gel of a control and a treated sample; C) corresponding autoradiograph. Equal amounts of the cytoskeletal fraction (50 μg) from control (C) and treated (T) samples were run in 7.5% polyacrylamide gel electrophoresis. MW: molecular weight standard proteins. Fig. 2 . Involvement of protein kinases on QUIN-induced IF in vitro hyperphosphorylation in striatum of 30 day-old rats. (A) Participation of second messenger dependent protein kinases PKA, PKCaMII and PKC was tested by using the specific inhibitors 10 μM H89, 10 μM KN93 and 1 μM staurosporina, respectively. (B) Participation of MEK/ERK, JNK, p38MAPK and Cdk5 was tested using the specific inhibitors 30 μM PD9859, 30 μM SP600125, 10 μM p38 MAPK inhibitor and 10 μM roscovitine, respectively. Slices were preincubated in the presence or absence of inhibitors for 10 min followed by incubation with 100 μM QUIN for 20 min. After, slices were incubated with 32 P-orthophosphate with or without 100 μM QUIN and/or inhibitors, as described in Materials and methods. The cytoskeletal fraction was extracted and the radioactivity incorporated into NFL, NFM, NFH and GFAP was measured. Data are reported as means ± S.D. of 18 animals in each group and expressed as % of control. Statistically significant differences from controls, as determined by one (DeFuria and , partially prevented NFM hyperphosphorylation. Furthermore, roscovitine, a Cdk5 inhibitor (Zhou et al., 2010) totally prevented NFM and NFH hyperphosphorylation (Fig. 2B) .
QUIN-induced signaling pathways targeting specific phosphorylating sites on NF subunits in striatal slices
In an attempt to identify the phosphorylating sites targeted by QUIN on NFL head domain, we assayed the immunoreactivity of NFLSer55 and NFLSer57 for PKA and PKCaMII, described to be regulatory sites for the NF assembly (Grant and Pant, 2000) . Western blot assays showed that the immunoreactivity with anti-phosphoSer55 and antiphosphoSer57 antibodies was increased in the cytoskeletal fraction of striatal slices exposed to QUIN. Moreover, phosphorylation of NFLSer55 was prevented by H89 and phosphorylation of NFLSer57 was prevented by KN93, PKA and PKCaMII inhibitors, respectively (Fig. 3A) . Moreover, the KSP repeats, located in the NFH tail domain were the targets for the action of QUIN, as demonstrated by Western blot assay with antiphosphoKSP repeat antibody. Interestingly, QA-induced phosphorylation of KSP repeats was totally prevented by MPEP (mGluR5 antagonist) and roscovitine, suggesting that QUIN would be upstream of mGluR5, which in turn, would activate cdk5 provoking hyperphosphorylation of the KSP repeat sites in the NFH tail domain (Fig. 3B) .
Participation of neurotransmitters in the action of QUIN in striatal slices: Testing the roles of glutamatergic and GABAergic systems
Since QUIN is considered a NMDA glutamate agonist (Schwarcz and Pellicciari, 2002; Stone, 1993) , we assayed the participation of glutamate receptors in the action of QUIN on the phosphorylating system associated with the IFs of the striatal neural cells. Tissue slices were coincubated with QUIN and DL-AP5, a competitive NMDA ionotropic antagonist, CNQX, a nonNMDA ionotropic antagonist and MCPG, a metabotropic glutamate antagonist. As shown in Fig. 4 , hyperphosphorylation induced by QUIN was totally prevented in the IF subunits by the NMDA antagonist, while CNQX attenuated the effect of QUIN on NFL. In addition, the metabotropic glutamate antagonist MCPG attenuated the action of QUIN on NFM. To further identify the types of mGluR involved in such action, we tested 4-C3-HPG and MPEP, specific mGluR1 and mGluR5 antagonists, respectively. Results showed that mGluR1 inhibition totally prevented the QUIN-induced hyperphosphorylation of NFL head domain sites. In addition, mGluR5 inhibition prevented the hyperphosphorylation of KSP repeats on NFM and NFH and partially in the head domain sites on NFL. Taken together, these findings suggest the participation of mGluRs in the action caused by QUIN on the dynamic phosphorylation of NF subunits.
We also, tested the involvement of the GABAergic system on the action of QUIN in vitro on the striatal tissue, since we have previously demonstrated that this neurotransmitter system was involved in the dynamics of the phosphorylating system associated with the IF proteins in brain slices (Funchal et al., 2004) . Moreover, Rekik et al. (2011) reported increased GABA B1 or GABA B2 immunoreactivity in the lesioned striatum after QUIN injection. In line with this, Fujiyama et al. (2002) described upregulation of GABA A receptors in the substantia nigra of rats that have received intrastriatal QUIN injection. However, results obtained in the present study with the specific antagonists for GABA A (bicuculine and pictrotoxin) and GABA B (phaclofen) receptors, respectively, indicated that IF hyperphosphorylation induced by QUIN was not mediated by the GABAergic system in striatal slices (results not shown). concerns to the cytoskeletal phosphorylation system (Funchal et al., 2004 (Funchal et al., , 2005a Loureiro et al., 2008; Stull, 2001) , we examined the involvement of Ca 2 + in the QUIN-mediated increase of the in vitro 32 P incorporation into IF in rat striatum. To test the involvement of Ca 2 + influx through voltage-dependent Ca 2 + channels (VDCC), we used the specific L-VDCC blocker verapamil. Results showed that coincubation of the tissue slices with QUIN and verapamil totally prevented the effect of QUIN on the phosphorylating system, suggesting that Ca 2 + influx via L-VDCC was involved in the ability of QUIN to alter the phosphorylating/dephosphorylating equilibrium of IF proteins recovered in the cytoskeletal fraction. To further investigate the role of intra and extracellular Ca 2 + levels in this process we performed experiments using EGTA, as an extracellular Ca 2 + chelator and BAPTA-AM the membrane-permeable form of BAPTA, an intracellular Ca 2 + chelator (Tymianski et al., 1994) . In the experiments designed to verify the involvement of the Ca 2 + release from the intracellular stores we used dantrolene, an inhibitor of ryanodine Ca 2 + channels of the endoplasmic reticulum. Taken together, the results showed that the action of QUIN was dependent on the cytosolic Ca 2 + levels and on the Ca 2 + influx from external medium in both neuronal and glial cells. In addition, dantrolene at a concentration described to irreversibly inhibit ryanodine channel opening (Serysheva and Hamilton, 1998) , prevented the IF hyperphosphorylation induced by QUIN (Fig. 5 ), in neurons, but not in astrocytes, which is consistent with the presence of these channels in excitable cell types, such as muscle and neurons (Bennett et al., 1996) . Finally, to characterize the role of phospholipase C in the QUINactivated signaling pathways targeting the IF-associated phosphorylating system, we used U73122, a specific PLC inhibitor. Results showed a partial involvement of PLC in the phosphorylation level of NFL, compatible with a role of diacylglycerol (DAG) in the activation of PKC and phosphorylation of head-domain phosphorylating sites on NFL (Fig. 2) .
Roles of Ca
Discussion
We have recently demonstrated that intrastriatal QUIN injection provoked the disruption of the homeostasis of the phosphorylating system associated with the cytoskeleton in neurons and in astrocytes of 30-day-old rats and that this effect was mediated by Ca 2 + influx through NMDA channels and by oxidative stress. We then proposed that alterations of the phosphorylation system associated with the IF proteins could represent an early event on the cascade of neurodegeneration mediated by QUIN in vivo (Pierozan et al., 2010) . Taking into account these findings and the relevance of the cytoskeleton in the physiology and pathophysiology of neural cells, we were interested to assess the molecular mechanisms underlying the actions of QUIN on the phosphorylating system associated with the cytoskeleton in the striatal astrocytes and neurons. Therefore, in the present report we used an in vitro model in which striatal slices of 30-dayold rats were exposed to 100 μM QUIN for 50 min demonstrating that QUIN, at a concentration described to induce excitotoxic effects in striatal slices (Perez-De La Cruz et al., 2010) , is upstream of complex signaling pathways provoking hyperphosphorylation of GFAP, the IF protein from mature astrocytes, as well as of NFL, NFM and NFH, constituents of neuronal IFs. It was found that QUIN disrupted the homeostasis of the cytoskeleton of astrocytes and neurons by cell specific mechanisms. In astrocytes, the action of QUIN was mediated by increased Ca 2 + influx through NMDA and L-VDCC channels. High Ca 2 + levels in the cytosol induced hyperphosphorylation of GFAP, by the second messengerdependent protein kinases PKA and PKCaMII. These findings are in agreement with the previous evidence showing that the neural isoforms of adenylyl cyclase are activated by Ca 2 + , supporting the PKA activation by high Ca 2 + levels (Steiner et al., 2006) . It is of note that PKCaMII is a Ca 2 + /calmodulin protein kinase implicated in the phosphorylation of sites in the head domain of type III IF proteins, including GFAP (Leal et al., 1997; Omary et al., 2006) .In this context, phosphorylation of the head domain of homopolymeric filaments like vimentin, desmin and GFAP is known to be important for filament assembly and plays a special role in dividing cells. Therefore, abnormal phosphorylation of the head domain sites of these type III IF proteins could lead to nonphysiological disassembly of IFs contributing to disruption of cell homeostasis (Gill et al., 1990; Heins et al., 1993) . In neurons QUIN elicited more complex actions involving metabotropic glutamate receptors and the release of Ca 2 + from intracellular stores besides Ca 2 + influx through NMDA and L-VDCC membrane channels. These events resulted in the hyperphosphorylation of both headdomain sites on NFL and tail-domain sites on NFM and NFH proteins. It was observed that in QUIN-induced hyperphosphorylation of NFL head domain sites was mediated by PKC, PKA and PKCaMII. NFL hyperphosphorylation was partially prevented by the mGluR1 antagonist and by inhibiting PLC activity. These findings indicate that QUIN is upstream of mGluR1/PLC pathway implicated in the hydrolysis of phosphatidyl inositol 4,5-biphosphate (PI(4,5)P 2 ) in neurons, producing inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) which, in turn, is able to activate PKC. Moreover, the use of site-and phosphorylation state-specific antibodies, as well as protein kinase inhibitors, pointed to PKA phosphorylating NFL subunit on Ser55 and PKCaMII phosphorylating NFL on Ser57. Differently from homopolymeric filaments, phosphorylation of the head domain sites on NFL was not involved in filament disassembly. NFs are present in the postmitotic neurons, and once formed, do not undergo depolymerization (Sihag et al., 2007) . Thus, the roles of head domain phosphorylation of rat NFL and NFM are thought to be related to the obligate heteropolymeric NF filament formation (Ching and Liem, 1999) , suggesting, therefore, that QUIN neurotoxicity in striatal slices includes destabilization of the IF network of neuronal cells. In this context, we have previously demonstrated that hyperphosphorylation of NFL on Ser55 is on the basis of neuronal dysfunction related to congenital hypothyroidism (Zamoner et al., 2008a) .
Moreover, the KSP repeats located on NFM and NFH carboxylterminal tail domains were hyperphosphorylated by cdk5, while JNK/ MAPK only partially contributed to NFM hyperphosphorylation in response to the QUIN insult. In this context, it has been described that Cdk5 phosphorylates cytoskeletal proteins, including the NFs and the microtubule associated protein Tau (Ackerley et al., 2003; Bu et al., 2002; Pant et al., 1997; Shea et al., 2004; Zhou et al., 2010) . Cdk5 is a member of the Cdk family, whose activity is predominantly detected in post-mitotic neurons (Hisanaga and Saito, 2003) . Two related proteins, p35 and p39, activate Cdk5 upon direct binding. During neurotoxic stress, intracellular rise in Ca 2 + activates calpain, which cleaves p35 to generate p25. The long half-life of Cdk5/p25 results in a hyperactive aberrant Cdk5 that hyperphosphorylates Tau, NF and other cytoskeletal proteins (Hisanaga and Saito, 2003) . It is known that carboxyl-terminal phosphorylation of NFH progressively restricts the association of neurofilaments with kinesin, the axonal anterograde motor protein, and stimulates its interaction with dynein, the axonal retrograde motor protein (Motil et al., 2006) . This event could represent one of the mechanisms by which carboxyl-terminal phosphorylation would slow neurofilament axonal transport. These hyperphosphorylated cytoskeletal proteins set the groundwork to forming neurofibrillary tangles and aggregates of phosphorylated proteins, that are hallmarks of neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and Amyotropic Lateral Sclerosis (Kanungo et al., 2008) . Proline-directed Cdk5 and MAP kinases are among the main prolinedirected kinases phosphorylating Ser residues on KSP tail domain on the NFM and NFH Sun et al., 1996; Veeranna et al., 1998) in response to signal transduction cascades triggered by a variety of signals (Dashiell et al., 2002; DeFuria and Shea, 2007; Li et al., 1999a Li et al., , 2000 , including Ca 2 + influx (Li et al., 1999b) . It is important to note that our results showing that QUIN induced NFM and NFH hyperphosphorylation was mediated by cdk5 while Erk and p38MAPK were not involved in this effect, and JNK partially phosphorylated NFM subunit. These findings could be correlated with cdk5-induced inactivation of the MAPK pathway Sharma et al., 2002) .
In the neuronal cells the glutamate receptors were also important mediators of the neurotoxicity of QUIN in striatal slices. We observed that hyperphosphorylation of NFL, NFM and NFH was dependent on NMDA as well as group I metabotropic glutamate receptors (mGluR1 and mGluR5), but not on AMPA and kainate receptors. However, we cannot exclude the possibility that QUIN-induced increase of IF phosphorylation through mGLUR could be due to and indirect effect of QUIN causing glutamate release. In this context, although Connick and Stone (1988) have described that high concentrations (2 mM and higher) of QUIN were able to release glutamate in vivo, this metabolite failed to induce glutamate release in concentrations as high as 5 mM in vitro. Therefore it is improbable that glutamate release could be provoked by QUIN (100 μM) in our experimental conditions. Activation of group I mGluRs by QUIN is consistent with a central role of these receptors in the striatum, whereas activation of mGlu1 and mGlu5 receptors exerts distinct actions, depending on the neuronal subtype involved (Bonsi et al., 2008) . Consistently with our results, the mGluR1/5 signal transduction is complex and involves multiple partners leading to activation of a wide variety of signaling pathways. It is noted that mGluRs coupled to Gα(q/) 11 proteins activated phospholipase Cβ1 resulting in DAG and IP3 formation is followed by PKC activation. In addition, mGluR activation can lead to modulation of a number of ion channels, such as different types of Ca 2 + and K + channels Fig. 6 . Proposed mechanism by which QUIN activates IF phosphorylation in neural cells of striatum of rats. The effects of QUIN are initiated by mGluR activation and excessive influx of Ca 2 + through NMDA receptors and L-VDCC, together with Ca 2 + release from intracellular stores leads to an overload of Ca 2 + within the cell, which set off a cascade of events including activation of PKA, PKCaMII and PKC, which phosphorylate head domain sites on GFAP and NFL subunits. Cdk5 is activated downstream of mGluR5 phosphorylating the KSP repeats of NFM and NFH, and mGluR1 is upstream of PLC which produces DAG which, in turn, activate PKC and phosphorylate NFL. (Ribeiro et al., 2010) . Also, mGluR5 is reported to be upstream of several kinases, including cdk5 (Wang et al., 2004) . Otherwise, activation of NMDA receptors is implicated in the increased cytoplasmic Ca 2 + concentrations, which in turn, can trigger a range of downstream neurotoxic cascades, including the activation and overstimulation of protein kinases (Szydlowska and Tymianski, 2010) . Regarding to the relevance of Ca 2 + overload on the modulation of the phosphorylating system associated with the cytoskeleton Loureiro et al., 2005 Loureiro et al., , 2010 Zamoner et al., 2008b) , the blockade of L-VDCC and the intra and extracellular Ca 2 + chelation totally prevented the effect of QUIN on IF phosphorylation. Interestingly, dantrolene-induced inhibition of Ca 2 + release from the endoplasmic reticulum through ryanodine receptors prevented this effect in neurons but was ineffective in astrocyte IFs, reinforcing the cell type specific signaling mechanisms. On the basis of our results QUIN increased cytosolic Ca 2 + in neural cells downstream of Ca 2 + influx through NMDA, L-VDCC and Ca 2 + release from intracellular stores.
These findings show the role of Ca 2 + in the actions of QUIN on the cytoskeleton. Taking into account our experimental results we could reach to the proposal depicted in Fig. 6 , that the in vitro action of QUIN on the endogenous phosphorylating system targeting the cytoskeleton of striatal cells is a complex intracellular process initiated by mGluR activation and excessive influx of Ca 2 + through NMDA receptors and L-VDCC.
These events, together with Ca 2 + release from intracellular stores lead to an overload of Ca 2 + within the cell. Elevated Ca 2 + levels then set off a cascade of events including activation of the second messenger-dependent protein kinases PKA, PKCaMII and PKC, which phosphorylate head domain sites on GFAP and NFL subunits and potentially misregulating IF assembly in both glial and neuronal cells. It was also found that Cdk5 is activated downstream of mGluR5, phosphorylating the KSP repeats on NFM and NFH. Also, mGluR1 is upstream of PLC which, in turn, produces DAG and IP3. Our results are also in accordance to the evidence that DAG is important to activate PKC and phosphorylate NFL, while IP3 contributes to Ca 2 + release from internal stores promoting hyperphosphorylation of KSP repeats on the tail domain of NFM and NFH. Besides the action on the phosphorylation sites on IF subunits, Cdk5 is probably able to inhibit MAPK pathway. Taking together, these signaling pathways eventually contribute to the fate of the affected astrocytes and neurons exposed to QUIN.
